2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Functional wiring of proteostatic and mitostatic modules ensures transient organismal survival during imbalanced mitochondrial dynamics

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Being an assembly of protein machines, cells depend on adequate supply of energetic molecules for retaining their homeodynamics. Consequently, mitochondria functionality is ensured by quality control systems and mitochondrial dynamics (fusion/fission). Similarly, proteome stability is maintained by the machineries of the proteostasis network. We report here that reduced mitochondrial fusion rates in Drosophila caused developmental lethality or if induced in the adult accelerated aging. Imbalanced mitochondrial dynamics were tolerable for various periods in young flies, where they caused oxidative stress and proteome instability that mobilized Nrf2 and foxo to upregulate cytoprotective antioxidant/proteostatic modules. Consistently, proteasome inhibition or Nrf2, foxo knock down in young flies exaggerated perturbed mitochondrial dynamics toxicity. Neither Nrf2 overexpression (with concomitant proteasome activation) nor Atg8a upregulation suppressed the deregulated mitochondrial dynamics toxicity, which was mildly mitigated by antioxidants. Thus, despite extensive functional wiring of mitostatic and antioxidant/proteostatic modules, sustained loss-of mitostasis exhausts adaptation responses triggering premature aging.

          Graphical abstract

          Highlights

          • Reduced mitochondrial fusion rates cause severe organismal toxicity and progeria.

          • Perturbed mitostasis activates cytoprotective antioxidant and proteostatic modules.

          • Nrf2 or Foxo KD exaggerates the imbalanced mitochondrial dynamics induced toxicity.

          • Antioxidants mildly alleviate loss-of mitochondrial dynamics-mediated progeria.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: not found
          • Article: not found

          Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Recognition and processing of ubiquitin-protein conjugates by the proteasome.

            The proteasome is an intricate molecular machine, which serves to degrade proteins following their conjugation to ubiquitin. Substrates dock onto the proteasome at its 19-subunit regulatory particle via a diverse set of ubiquitin receptors and are then translocated into an internal chamber within the 28-subunit proteolytic core particle (CP), where they are hydrolyzed. Substrate is threaded into the CP through a narrow gated channel, and thus translocation requires unfolding of the substrate. Six distinct ATPases in the regulatory particle appear to form a ring complex and to drive unfolding as well as translocation. ATP-dependent, degradation-coupled deubiquitination of the substrate is required both for efficient substrate degradation and for preventing the degradation of the ubiquitin tag. However, the proteasome also contains deubiquitinating enzymes (DUBs) that can remove ubiquitin before substrate degradation initiates, thus allowing some substrates to dissociate from the proteasome and escape degradation. Here we examine the key elements of this molecular machine and how they cooperate in the processing of proteolytic substrates.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Rapamycin: one drug, many effects.

              The mammalian target of rapamycin (mTOR) signaling pathway is a master regulator of cell growth and metabolism. Deregulation of the mTOR pathway has been implicated in a number of human diseases such as cancer, diabetes, obesity, neurological diseases, and genetic disorders. Rapamycin, a specific inhibitor of mTOR, has been shown to be useful in the treatment of certain diseases. Here we discuss its mechanism of action and highlight recent findings regarding the effects and limitations of rapamycin monotherapy and the potential utility of combination therapy with rapamycin. Copyright © 2014 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Journal
                Redox Biol
                Redox Biol
                Redox Biology
                Elsevier
                2213-2317
                17 May 2019
                June 2019
                17 May 2019
                : 24
                : 101219
                Affiliations
                [a ]Department of Cell Biology and Biophysics, Faculty of Biology, National & Kapodistrian University of Athens, 15784, Greece
                [b ]Dulbecco-Telethon Institute, Venetian Institute of Molecular Medicine and Department of Biology, University of Padua, Padova, 35129, Italy
                Author notes
                []Corresponding author. Department of Cell Biology and Biophysics, Faculty of Biology, University of Athens, Panepistimiopolis, Athens, 15784, Greece. itrougakos@ 123456biol.uoa.gr
                [1]

                equal contribution.

                Article
                S2213-2317(19)30412-4 101219
                10.1016/j.redox.2019.101219
                6536731
                31132524
                6bf158ae-308e-4490-89a5-b7af21d86593
                © 2019 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 3 April 2019
                : 4 May 2019
                : 13 May 2019
                Categories
                Research Paper

                aging,drp1,mitofusins,mitostasis,opa1,proteostasis
                aging, drp1, mitofusins, mitostasis, opa1, proteostasis

                Comments

                Comment on this article